For a 10-year horizon, does NVDA’s dominance justify overweight, or is SPY’s compounding still the safer bet?
AI chips still dominate headlines, but the broader tech beta in SPY keeps catching up; interesting divergence between semis and the index.
Trim NVDA or add SPY here?
In cloud and AI, MSFT still leads on revenue and margins, while NVDA and AMZN keep stealing headlines. Pricing power looks intact.
Seen this before—breakouts fade without earnings.
So basically MSFT just hit 505, is that a new support or just noise? Anyone else buying the move?
Why sell FLU/CIC now? Are royalties really enough to offset R&D, or is this just a liquidity squeeze?
Everyone’s cheering the cash, but I think this is a classic pivot: offload non-core, reinvest in core, and wait for SNY/PFE milestones. NVAX might underperform short term, then outpace peers once royalties compound.
Feels like rate sensitivity kicking in; cash moves matter.
Feels like a distraction. With sticky inflation and higher-for-longer rates, blaming someone else doesn’t fix the policy path or balance sheet.
Market’s pricing in a policy reset, but headlines keep shifting blame. If rates stay elevated and growth lags, the next leg up probably needs stronger data, not just optics. Watching TLT and SPY for confirmation.
Kinda bullish on calm after this political noise.
Not in yet. If this rally fades into earnings week, I’d rather wait for a pullback and a cleaner setup.
Is this just a pump or real breakout?
NVDA ripping on volume, but I’m fading spikes into resistance. If $BTC wobbles, I’ll scalp the AI beta.
